Author

Agnès Saint-Raymond

Observed names: A Saint-Raymond, A Saint‐Raymond, A. Saint Raymond, A. Saint-Raymond, A. Saint‐Raymond, A.Saint Raymond, Agnes Saint Raymond, Agnes Saint-Raymond, Agnes Saint‐Raymond, Agnès Saint Raymond, Agnés Saint Raymond, Saint-Raymond, Agnès

Institution: Concept Foundation

Observed institutions: Hôpital Necker-Enfants Malades, European Medicines Agency, Italian Medicines Agency, Concept Foundation

ORCID: 0000-0001-8056-8453

Observed ORCID: 0000-0001-8056-8453

OpenAlex ID: A5062661532

Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options

2009 · A. C. Ludolph, J. Kassubek, et al. · European Journal of Neurology · 174

Role of modeling and simulation in pediatric investigation plans

2011 · Efthymios Manolis, Tariq Eldirdiry Osman, et al. · Pediatric Anesthesia · 91

Enabling Development of Paediatric Medicines in Europe: 10 Years of the EU Paediatric Regulation

2017 · Paolo A. Tomasi, Gunter F. Egger, et al. · Pediatric Drugs · 84

A European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA)

2011 · Nicolino Ruperto, Irmgard Eichler, et al. · Archives of Disease in Childhood · 74

Three years of paediatric regulation in the European Union

2011 · Thorsten M. Olski, Simona F. Lampus, et al. · European Journal of Clinical Pharmacology · 73

Fostering responsible research with genome editing technologies: a European perspective

2017 · Hervé Chneiweiss, François Hirsch, et al. · Transgenic Research · 68

PDF

Comparison Between Paediatric and Adult Suspected Adverse Drug Reactions Reported to the European Medicines Agency: Implications for Pharmacovigilance

2014 · Kevin V. Blake, Cosimo Zaccaria, et al. · Pediatric Drugs · 66

Are the European Medicines Agency, US Food and Drug Administration, and Other International Regulators Talking to Each Other?

2019 · Tania Teixeira, Sandra L. Kweder, et al. · Clinical Pharmacology & Therapeutics · 54

PDF

CONSORT 2010

2010 · Agnès Saint-Raymond, Suzanne Hill, et al. · The Lancet · 49

PDF

Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency

2018 · Olivier Collignon, Franz Koenig, et al. · Trials · 47

Paediatric extrapolation: A necessary paradigm shift

2018 · Cécile Ollivier, Yeruk (Lily) Mulugeta, et al. · British Journal of Clinical Pharmacology · 44

PDF

Pediatric Regulatory Initiatives

2011 · Steven Hirschfeld, Agnes Saint-Raymond · Handbook of experimental pharmacology · 43

Assuring Access to Safe Medicines in Pregnancy and Breastfeeding

2021 · Janet Nooney, Shannon Thor, et al. · Clinical Pharmacology & Therapeutics · 41

PDF

Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations

2017 · Martina Penazzato, Devasena Gnanashanmugam, et al. · Clinical Infectious Diseases · 39

PDF

Guidance for Clinical Trials for Children and Adolescents With Chronic Hepatitis C

2010 · Stefan Wirth, Deirdre Kelly, et al. · Journal of Pediatric Gastroenterology and Nutrition · 37

Impact of the European paediatric legislation in paediatric rheumatology: past, present and future

2013 · Nicolino Ruperto, Richard Vesely, et al. · Annals of the Rheumatic Diseases · 36

Juvenile animal studies for the development of paediatric medicines: a description and conclusions from a European medicines agency workshop on juvenile animal testing for nonclinical assessors

2010 · Beatriz Silva‐Lima, Mette Due Theilade‐Thomsen, et al. · Birth Defects Research Part B Developmental and Reproductive Toxicology · 35

Development of medicines for children in Europe: ethical implications

2005 · Agnès Saint Raymond, Daniel Brasseur · Paediatric Respiratory Reviews · 35

WHO collaborative registration procedure using stringent regulatory authorities’ medicine evaluation: reliance in action?

2022 · Alexandra Vaz, Mariana Roldão Santos, et al. · Expert Review of Clinical Pharmacology · 34

The EMA quality guideline on the pharmaceutical development of medicines for paediatric use

2012 · Diana A. van Riet-Nales, Siri Wang, et al. · International Journal of Pharmaceutics · 32

Remdesivir emergency approvals: a comparison of the U.S., Japanese, and EU systems

2020 · A Saint-Raymond, J Sato, et al. · Expert Review of Clinical Pharmacology · 27

The European Medicines Agency facilitates access to medicines in low- and middle-income countries

2020 · Maria Cavaller Bellaubi, Martin Harvey Allchurch, et al. · Expert Review of Clinical Pharmacology · 27

PDF

Oral Medicines for Children in the European Paediatric Investigation Plans

2014 · Diana A. van Riet – Nales, Erwin G. A. W. Römkens, et al. · PLoS ONE · 25

PDF

Reliance: a smarter way of regulating medical products - The IPRP survey

2020 · Petra Doerr, Marie Valentin, et al. · Expert Review of Clinical Pharmacology · 23

Increased PIVKA-II concentrations in patients with cystic fibrosis.

1992 · M de Montalembert, G Lenoir, et al. · Journal of Clinical Pathology · 22

PDF

Works count: 68

Citation count: 1,500

H-index: 23

I10-index: 35